...
【24h】

Thank you to Reviewers

机译:谢谢审稿人

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background:Although a positive surgical margin (PSM) at radical prostatectomy (RRP) has been consistently linked to an increased risk of biochemical recurrence, the impact of margin status on patient survival continues to be debated. We evaluated long-term outcomes of patients with a PSM at RRP and determined predictors of systemic progression (SP) and mortality in these men.Methods:We reviewed our institutional registry of 16 749 patients who underwent RRP between 1990 and 2008 to identify 2895 patients with a PSM. Median follow-up was 10.6 years. Postoperative survival was estimated using the Kaplan-Meier method. Cox proportional hazard regression models were used to analyze clinicopathological variables associated with SP and death from prostate cancer.Results:A 15-year SP-free and cancer-specific survival was 90 and 93%, respectively. On multivariate analysis, higher tumor volume, increased pathological Gleason score and advanced pathological tumor stage were associated with significantly increased risks of SP and death from prostate cancer, whereas number and location of PSM did not predict mortality.Conclusions:The risks of SP and prostate cancer death in patients with a PSM remain low on long-term follow-up. Tumor variables are the primary determinants of cancer death. These results should be considered when evaluating patients with a PSM for adjuvant therapy.
机译:背景:尽管根治性前列腺切除术(RRP)的手术切缘阳性(PSM)一直与生化复发风险增加有关,但切缘状况对患者生存的影响仍在争论中。我们评估了RSM的PSM患者的长期结局,并确定了这些男性的系统性进展(SP)和死亡率的预测因素。方法:我们回顾了1990年至2008年间16749例接受RRP的患者的机构注册资料,以确定2895例患者与PSM。中位随访时间为10。6年。使用Kaplan-Meier方法评估术后生存期。使用Cox比例风险回归模型分析与SP和前列腺癌死亡相关的临床病理变量。结果:无SP的15年生存率和特定于癌症的生存率分别为90%和93%。在多变量分析中,较高的肿瘤体积,增加的病理Gleason评分和晚期的病理肿瘤分期与SP的风险和前列腺癌的死亡显着增加相关,而PSM的数量和位置并不能预测死亡率。长期随访发现,PSM患者的癌症死亡人数仍然很低。肿瘤变量是癌症死亡的主要决定因素。在评估患有PSM的患者进行辅助治疗时,应考虑这些结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号